Related Experiment Video
Updated: Feb 5, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart
Werner Mohl1, Ernest Spitzer2, Robert M Mader3
1Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Aims:
Cardiac repair has steered clinical attention and remains an unmet need, because available regenerative therapies lack robust mechanistic evidence. Pressure-controlled intermittent coronary sinus occlusion (PICSO), known to induce angiogenetic and vasoactive molecules as well as to reduce regional ischemia, may activate endogenous regenerative processes in failing myocardium. We aimed to investigate the effects of PICSO in patients with advanced heart failure undergoing cardiac resynchronization therapy.
Methods And Results:
Eight out of 32 patients were treated with PICSO, and the remainder served as controls. After electrode testing including left ventricular leads, PICSO was performed for 20 min. To test immediate molecular responses, in both patient groups, coronary venous blood samples were taken at baseline and after 20 min, the time required for the intervention. Sera were tested for microRNAs and growth factors. To test the ability of up-regulated soluble factors on cell proliferation and expression of transcription factors [e.g. Krüppel-like factor 4 (KLF-4)], sera were co-cultured with human cardiomyocytes and fibroblasts. As compared with controls, significant differential expression (differences between pre-values and post-values in relation to both patient cohorts) of microRNA patterns associated with cardiac development was observed with PICSO. Importantly, miR-143 (P < 0.048) and miR-145 (P < 0,047) increased, both targeting a network of transcription factors (including KLF-4) that promote differentiation and repress proliferation of vascular smooth muscle cells. Additionally, an increase of miR-19b (P < 0.019) known to alleviate endothelial cell apoptosis was found, whereas disadvantageous miR-320b (P < 0.023) suspect to impair expression of c-myc, normally provoking cell cycle re-entry in post-mitotic myocytes and miR-25 (P < 0.023), decreased, a target of anti-miR application to improve contractility in the failing heart. Co-cultured post-PICSO sera significantly increased cellular proliferation both in fibroblasts (P < 0.001) and adult cardiomycytes (P < 0.004) sampled from a transplant recipient as compared with controls. Adult cardiomyocytes showed a seven-fold increase of the transcription factor KLF-4 protein when co-cultured with treated sera as compared with controls.
Conclusions:
Here, we show for the first time that PICSO, a trans-coronary sinus catheter intervention, is associated with an increase in morphogens secreted into cardiac veins, normally present during cardiac development, and a significant induction of cell proliferation. Present findings support the notion that epigenetic modifications, that is, haemodynamic stimuli on venous vascular cells, may reverse myocardial deterioration. Further investigations are needed to decipher the maze of complex interacting molecular pathways in failing myocardium and the potential role of PICSO to reinitiate developmental processes to prevent further myocardial decay eventually reaching clinical significance.
Insights
Pressure-controlled intermittent coronary sinus occlusion (PICSO) therapy may activate the heart's natural repair mechanisms. This study found PICSO increased cardiac development molecules and cell proliferation in advanced heart failure patients.
Area of Science:
- Cardiology
- Regenerative Medicine
- Molecular Biology
Background:
- Cardiac repair remains a significant clinical challenge with limited effective regenerative therapies.
- Pressure-controlled intermittent coronary sinus occlusion (PICSO) is known to induce beneficial molecular changes and reduce ischemia.
- PICSO may potentially activate endogenous regenerative processes in failing heart muscle.
Purpose of the Study:
- To investigate the effects of PICSO on molecular changes and cellular responses in patients with advanced heart failure.
- To assess PICSO's potential to activate endogenous cardiac regenerative processes.
Main Methods:
- A prospective study involving 32 advanced heart failure patients undergoing cardiac resynchronization therapy.
- Eight patients received PICSO intervention for 20 minutes; the rest served as controls.
- Coronary venous blood samples were analyzed for microRNAs and growth factors; sera were used for cell proliferation assays.
Main Results:
- PICSO treatment led to significant differential expression of microRNAs associated with cardiac development, including increased miR-143 and miR-145.
- PICSO increased miR-19b, known to reduce endothelial cell apoptosis, and decreased miR-320b and miR-25.
- Sera from PICSO-treated patients significantly enhanced proliferation in human cardiomyocytes and fibroblasts, with a seven-fold increase in KLF-4 protein.
Conclusions:
- PICSO intervention increases cardiac morphogens and induces significant cell proliferation, suggesting a role in activating developmental pathways.
- Findings support the hypothesis that hemodynamic stimuli via PICSO can induce epigenetic modifications to reverse myocardial deterioration.
- Further research is needed to elucidate the complex molecular pathways involved and PICSO's clinical potential in cardiac regeneration.
Related Concept Videos
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction

